Articles
-
Jun 21, 2024 |
mdpi.com | Harry Wilton-Clark |Eric Yan |Toshifumi Yokota
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
Jun 4, 2024 |
mdpi.com | Jamie N. Leckie |Toshifumi Yokota
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
May 29, 2024 |
preprints.org | Harry Wilton-Clark |Eric Yan |Toshifumi Yokota
PreprintReviewVersion 1This version is not peer-reviewedVersion 1: Received: 29 May 2024 / Approved: 29 May 2024 / Online: 29 May 2024 (12:08:10 CEST)Wilton-Clark, H.; Yan, E.; Yokota, T. Preparing for patient-customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases. Preprints 2024, 2024051955. https://doi.org/10.20944/preprints202405.1955.v1Wilton-Clark, H.; Yan, E.; Yokota, T. Preparing for patient-customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases.
Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA
May 6, 2024 |
preprints.org | Jamie N. Leckie |Toshifumi Yokota
Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 6 May 2024 / Approved: 6 May 2024 / Online: 6 May 2024 (09:54:35 CEST) Leckie, J.; Yokota, T. Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA. Preprints 2024, 2024050274. https://doi.org/10.20944/preprints202405.0274.v1 Leckie, J.; Yokota, T. Potential of Cell-Penetrating Peptide-Conjugated Antisense Oligonucleotides for the Treatment of SMA.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →